A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03864627 · TERMINATED
Trial details
- NCT number
- NCT03864627
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-25
- Primary completion
- 2020-02-27
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.